Our previous transcriptomic analyses comparing high-ELAVL1-expressing PCa with low-ELAVL1-expressing PCa revealed the significant enrichment of RNA metabolism-related genes and altered expression of m6A modification factors in tumors with high ELAVL1 levels. The gene discussed is ELAVL1; the disease is posterior cortical atrophy.